These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8852504)

  • 21. Effects of an aqueous extract from Phyllantus niruri on calcium oxalate crystallization in vitro.
    Barros ME; Schor N; Boim MA
    Urol Res; 2003 Feb; 30(6):374-9. PubMed ID: 12599017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).
    Conte A; Pizá P; García-Raja A
    Arch Esp Urol; 1999; 52(1):94-9. PubMed ID: 10101897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissolution of struvite urinary stones. Experimental studies in vitro.
    Griffith DP; Bragin S; Musher DM
    Invest Urol; 1976 Mar; 13(5):351-3. PubMed ID: 1254428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Staining of uric acid crystals with methylene blue].
    Kleeberg J
    Z Urol Nephrol; 1972 Aug; 65(8):619-29. PubMed ID: 4119477
    [No Abstract]   [Full Text] [Related]  

  • 26. [Determination of the composition of renal calculi by x-ray spectrometry].
    Di Silverio F; Tenaglia R; Gentile V; Giacobini S; D'Eramo G; Pannunzio E; Tronca A; Bianchi B
    Minerva Med; 1984 Jun; 75(26):1579-88. PubMed ID: 6738908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preservation of urine samples for metabolic evaluation of stone-forming patients.
    Ferraz RR; Baxmann AC; Ferreira LG; Nishiura JL; Siliano PR; Gomes SA; Moreira SR; Heilberg IP
    Urol Res; 2006 Oct; 34(5):329-37. PubMed ID: 16896690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Urinary pH and stones].
    THOMAS J; THOMAS E
    Rev Prat; 1955 Jun; 5(16):1683-7. PubMed ID: 14396114
    [No Abstract]   [Full Text] [Related]  

  • 29. [The Sarig test. A simple method to evaluate the inhibitory effect on urinary crystallization of calcium oxalate].
    Tizzani A; Casetta G; Cavallini A; Piana P; Squintone L; Vottero M
    Minerva Urol Nefrol; 1991; 43(4):265-8. PubMed ID: 1812569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study on concretions developed around urinary catheters and mechanisms of renal calculi development.
    Grases F; Söhnel O; Costa-Bauzá A; Ramis M; Wang Z
    Nephron; 2001 Aug; 88(4):320-8. PubMed ID: 11474226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effects of urinary macromolecules on the crystallization of calcium oxalate.
    Gill WB; Karesh JW; Garsin L; Roma MJ
    Invest Urol; 1977 Sep; 15(2):95-9. PubMed ID: 903217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does a failure of crystal inhibition cause calcium renal stones?
    Coe FL; Parks JH
    Nephron; 2002 Apr; 90(4):361-4. PubMed ID: 11961392
    [No Abstract]   [Full Text] [Related]  

  • 33. [Correlations between crystalluria and composition of calculi].
    Kaid-Omar Z; Daudon M; Attar A; Semmoud A; Lacour B; Addou A
    Prog Urol; 1999 Sep; 9(4):633-41. PubMed ID: 10555214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zeta potential measurement and particle size analysis for a better understanding of urinary inhibitors of calcium oxalate crystallization.
    Cao LC; Deng G; Boevé ER; de Bruijn WC; de Water R; Verkoelen CF; Romijn JC; Schröder FH
    Scanning Microsc; 1996; 10(2):401-11; discussion 412-4. PubMed ID: 9813619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concentrated urine and diluted urine: the effects of citrate and magnesium on the crystallization of calcium oxalate induced in vitro by an oxalate load.
    Guerra A; Meschi T; Allegri F; Prati B; Nouvenne A; Fiaccadori E; Borghi L
    Urol Res; 2006 Dec; 34(6):359-64. PubMed ID: 16953377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Artificial simulation of renal stone formation. Influence of some urinary components.
    Grases F; Costa-Bauzá A; March JG; Söhnel O
    Nephron; 1993; 65(1):77-81. PubMed ID: 8413796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary glycosaminoglycans and glycoproteins in a calcium oxalate crystallization system.
    Poon NW; Gohel MD
    Carbohydr Res; 2012 Jan; 347(1):64-8. PubMed ID: 22119438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal attachment to injured renal collecting duct cells: influence of urine proteins and pH.
    Wiessner JH; Hung LY; Mandel NS
    Kidney Int; 2003 Apr; 63(4):1313-20. PubMed ID: 12631348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of urine dilution on quantity, size and aggregation of calcium oxalate crystals induced in vitro by an oxalate load.
    Guerra A; Allegri F; Meschi T; Adorni G; Prati B; Nouvenne A; Novarini A; Maggiore U; Fiaccadori E; Borghi L
    Clin Chem Lab Med; 2005; 43(6):585-9. PubMed ID: 16006253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of hematuria in diagnosing kidney stones.
    Koenig CJ; Lindbloom EJ
    J Fam Pract; 1999 Nov; 48(11):912-3. PubMed ID: 10907632
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.